Schistosoma haematobium antigen

Known as: Schistosoma haematobium 
 

Topic mentions per year

Topic mentions per year

1948-2017
010203019482016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Schistosoma haematobium is the etiologic agent for urogenital schistosomiasis, a major source of morbidity and mortality for more… (More)
Is this relevant?
2011
2011
BACKGROUND Minimal information on the genome and proteome of Schistosoma haematobium is available, in marked contrast to the… (More)
Is this relevant?
2011
2011
OBJECTIVES Squamous cell carcinoma of the urinary bladder has been associated with Schistosoma haematobium infection in many… (More)
Is this relevant?
2011
2011
BACKGROUND Close to 800 million people in the world are at risk of schistosomiasis, 85 per cent of whom live in Africa. Recent… (More)
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2007
Highly Cited
2007
BACKGROUND In sub-Saharan Africa, 112 million people are infected with Schistosoma haematobium, with the most intense infections… (More)
Is this relevant?
2006
2006
A single 40 mg/kg dose of praziquantel (PZQ) continues to be the standard treatment for schistosomiasis caused by S. mansoni and… (More)
Is this relevant?
2005
2005
Millions of humans are exposed to schistosome infections, which cause severe kidney and liver disease and 280,000 deaths annually… (More)
  • table I
  • figure 1
  • figure 2
  • table II
  • table III
Is this relevant?
1998
1998
Acquired immunity to human schistosomiasis correlates with increased serum levels of schistosome antigen-specific IgE. Since… (More)
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
1998
1998
Little is known about the dynamics of pathology due to schistosomiasis following treatment. Public health authorities in endemic… (More)
Is this relevant?
1994
1994
A cohort of 148 Cameroonian children infected with Schistosoma haematobium was followed before praziquantel therapy and 1, 2, 3… (More)
Is this relevant?